Page last updated: 2024-08-22

tricalcium phosphate and Pituitary Diseases

tricalcium phosphate has been researched along with Pituitary Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chihara, K; Fumoto, M; Iguchi, G; Iida, K; Kaji, H; Kishimoto, M; Okimura, Y	1

Other Studies

1 other study(ies) available for tricalcium phosphate and Pituitary Diseases

Article	Year
The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes. European journal of endocrinology, 2003, Volume: 148, Issue:6 Topics: Animals; Calcium Phosphates; Cell Nucleus; CHO Cells; COS Cells; Cricetinae; DNA-Binding Proteins; Genes, Reporter; Human Growth Hormone; Humans; Luciferases; Mutagenesis; Pituitary Diseases; Point Mutation; Prolactin; Promoter Regions, Genetic; Transcription Factor Pit-1; Transcription Factors; Transfection	2003

Article

Year

The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes.

European journal of endocrinology, 2003, Volume: 148, Issue:6

Topics: Animals; Calcium Phosphates; Cell Nucleus; CHO Cells; COS Cells; Cricetinae; DNA-Binding Proteins; Genes, Reporter; Human Growth Hormone; Humans; Luciferases; Mutagenesis; Pituitary Diseases; Point Mutation; Prolactin; Promoter Regions, Genetic; Transcription Factor Pit-1; Transcription Factors; Transfection

2003